Cancer Research PRL Inhibitor Induces the Cleavage of p130Cas  Sign up for Cancer Research eTOC's
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 46, 6064-6067, December 1, 1986]
© 1986 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by El-Bayoumy, K.
Right arrow Articles by Hoffmann, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by El-Bayoumy, K.
Right arrow Articles by Hoffmann, D.

Identification and Quantitative Determination of Aniline and Toluidines in Human Urine1

Karam El-Bayoumy2, Jean M. Donahue, Stephen S. Hecht and Dietrich Hoffmann

Naylor Dana Institute for Disease Prevention, American Health Foundation, Valhalla, New York 10595

Aniline and o-, m-, and p-toluidine, which are representative of aromatic amines in cigarette smoke, were identified and quantified in human urine. Smokers excreted 3.1 ± 2.6 µg/24 h of aniline and 6.3 ± 3.7 µg/24 h of o-toluidine (n = 16). Nonsmokers excreted 2.8 ± 2.5 µg/24 h of aniline and 4.1 ± 3.2 µg/24 h of o-toluidine (n = 12). Meta- and p-toluidine were detected in the urine of 2 of 11 smokers and 4 of 9 nonsmokers. The observed intra- and interindividual variations in the amounts of urinary aniline and o-toluidine were relatively large. The results of this study demonstrate for the first time that aniline and toluidines are present in human urine and suggest that sources other than cigarette smoke contribute significantly to their concentrations in urine.

1 This study was supported by National Cancer Institute Grant CA-29580. This is Paper No. XXXIII in the series, "A Study of Tobacco Carcinogenesis."

2 To whom requests for reprints should be addressed.

Received 3/31/86. Revised 6/30/86. Accepted 7/31/86.




This article has been cited by other articles:


Home page
CarcinogenesisHome page
T. Kawamori, Y. Totsuka, N. Uchiya, T. Kitamura, H. Shibata, T. Sugimura, and K. Wakabayashi
Carcinogenicity of aminophenylnorharman, a possible novel endogenous mutagen, formed from norharman and aniline, in F344 rats
Carcinogenesis, October 1, 2004; 25(10): 1967 - 1672.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
K.-i. Masumura, Y. Totsuka, K. Wakabayashi, and T. Nohmi
Potent genotoxicity of aminophenylnorharman, formed from non-mutagenic norharman and aniline, in the liver of gpt delta transgenic mouse
Carcinogenesis, December 1, 2003; 24(12): 1985 - 1993.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. S. Hecht
Human urinary carcinogen metabolites: biomarkers for investigating tobacco and cancer
Carcinogenesis, June 1, 2002; 23(6): 907 - 922.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1986 by the American Association for Cancer Research.